Sodium channel mutations and arrhythmias.

Yanfei Ruan, Nian Liu, Silvia G. Priori

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

Since the identification of the first SCN5A mutation associated with long QT syndrome in 1995, several mutations in this gene for the alpha subunit of the cardiac sodium channel have been identified in a heterogeneous subset of cardiac rhythm syndromes, including Brugada syndrome, progressive cardiac conduction defect, sick sinus node syndrome, atrial fibrillation and dilated cardiomyopathy. Robust clinical evidence has been accompanied by bench studies performed in different models spanning from in vitro expression systems to transgenic mice. Together, these studies have helped establish genotype-phenotype correlations and have shaped our understanding of the role of the cardiac sodium channel in health and in disease. Remarkably, these advances in understanding have impacted on clinical management by allowing us to start developing gene-specific risk stratification schemes and mutation-specific management strategies. In this Review, we summarize the current understanding of the molecular mechanism of SCN5A-associated inherited arrhythmias, focusing on the most recent development of mutation-specific management in SCN5A-associated long QT syndrome type 3. We also briefly discuss arrhythmia-causing mutations in the genes encoding the beta subunit of the cardiac sodium channel and in those encoding proteins in the associated macromolecular complex.

Original languageEnglish
Pages (from-to)337-348
Number of pages12
JournalNature Reviews Cardiology
Volume6
Issue number5
DOIs
Publication statusPublished - May 2009

Fingerprint

Sodium Channels
Cardiac Arrhythmias
Mutation
Brugada Syndrome
Genes
Macromolecular Substances
Sick Sinus Syndrome
Long QT Syndrome
Dilated Cardiomyopathy
Genetic Association Studies
Atrial Fibrillation
Transgenic Mice
Health
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sodium channel mutations and arrhythmias. / Ruan, Yanfei; Liu, Nian; Priori, Silvia G.

In: Nature Reviews Cardiology, Vol. 6, No. 5, 05.2009, p. 337-348.

Research output: Contribution to journalArticle

Ruan, Yanfei ; Liu, Nian ; Priori, Silvia G. / Sodium channel mutations and arrhythmias. In: Nature Reviews Cardiology. 2009 ; Vol. 6, No. 5. pp. 337-348.
@article{2d3ef8c9ae9d43fabce6c7ba79fc466b,
title = "Sodium channel mutations and arrhythmias.",
abstract = "Since the identification of the first SCN5A mutation associated with long QT syndrome in 1995, several mutations in this gene for the alpha subunit of the cardiac sodium channel have been identified in a heterogeneous subset of cardiac rhythm syndromes, including Brugada syndrome, progressive cardiac conduction defect, sick sinus node syndrome, atrial fibrillation and dilated cardiomyopathy. Robust clinical evidence has been accompanied by bench studies performed in different models spanning from in vitro expression systems to transgenic mice. Together, these studies have helped establish genotype-phenotype correlations and have shaped our understanding of the role of the cardiac sodium channel in health and in disease. Remarkably, these advances in understanding have impacted on clinical management by allowing us to start developing gene-specific risk stratification schemes and mutation-specific management strategies. In this Review, we summarize the current understanding of the molecular mechanism of SCN5A-associated inherited arrhythmias, focusing on the most recent development of mutation-specific management in SCN5A-associated long QT syndrome type 3. We also briefly discuss arrhythmia-causing mutations in the genes encoding the beta subunit of the cardiac sodium channel and in those encoding proteins in the associated macromolecular complex.",
author = "Yanfei Ruan and Nian Liu and Priori, {Silvia G.}",
year = "2009",
month = "5",
doi = "10.1038/nrcardio.2009.44",
language = "English",
volume = "6",
pages = "337--348",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Sodium channel mutations and arrhythmias.

AU - Ruan, Yanfei

AU - Liu, Nian

AU - Priori, Silvia G.

PY - 2009/5

Y1 - 2009/5

N2 - Since the identification of the first SCN5A mutation associated with long QT syndrome in 1995, several mutations in this gene for the alpha subunit of the cardiac sodium channel have been identified in a heterogeneous subset of cardiac rhythm syndromes, including Brugada syndrome, progressive cardiac conduction defect, sick sinus node syndrome, atrial fibrillation and dilated cardiomyopathy. Robust clinical evidence has been accompanied by bench studies performed in different models spanning from in vitro expression systems to transgenic mice. Together, these studies have helped establish genotype-phenotype correlations and have shaped our understanding of the role of the cardiac sodium channel in health and in disease. Remarkably, these advances in understanding have impacted on clinical management by allowing us to start developing gene-specific risk stratification schemes and mutation-specific management strategies. In this Review, we summarize the current understanding of the molecular mechanism of SCN5A-associated inherited arrhythmias, focusing on the most recent development of mutation-specific management in SCN5A-associated long QT syndrome type 3. We also briefly discuss arrhythmia-causing mutations in the genes encoding the beta subunit of the cardiac sodium channel and in those encoding proteins in the associated macromolecular complex.

AB - Since the identification of the first SCN5A mutation associated with long QT syndrome in 1995, several mutations in this gene for the alpha subunit of the cardiac sodium channel have been identified in a heterogeneous subset of cardiac rhythm syndromes, including Brugada syndrome, progressive cardiac conduction defect, sick sinus node syndrome, atrial fibrillation and dilated cardiomyopathy. Robust clinical evidence has been accompanied by bench studies performed in different models spanning from in vitro expression systems to transgenic mice. Together, these studies have helped establish genotype-phenotype correlations and have shaped our understanding of the role of the cardiac sodium channel in health and in disease. Remarkably, these advances in understanding have impacted on clinical management by allowing us to start developing gene-specific risk stratification schemes and mutation-specific management strategies. In this Review, we summarize the current understanding of the molecular mechanism of SCN5A-associated inherited arrhythmias, focusing on the most recent development of mutation-specific management in SCN5A-associated long QT syndrome type 3. We also briefly discuss arrhythmia-causing mutations in the genes encoding the beta subunit of the cardiac sodium channel and in those encoding proteins in the associated macromolecular complex.

UR - http://www.scopus.com/inward/record.url?scp=67649547603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649547603&partnerID=8YFLogxK

U2 - 10.1038/nrcardio.2009.44

DO - 10.1038/nrcardio.2009.44

M3 - Article

C2 - 19377496

AN - SCOPUS:67649547603

VL - 6

SP - 337

EP - 348

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 5

ER -